Clinical trial
Early Ultrasound and Maternal Biochemical Markers to Evaluate the Risk of Down…
NCT00287417 · University Hospital, Strasbourg, France, Other · Completed
Key facts
| NCT number | NCT00287417 |
|---|---|
| Title | Early Ultrasound and Maternal Biochemical Markers to Evaluate the Risk of Down Syndrome During the First Trimester |
| Official title | Nuchal Translucency Study - PAPP-A |
| Lead sponsor | University Hospital, Strasbourg, France, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Down Syndrome |
| Intervention type | Device, Other |
| Interventions | echography, blood sample |
| Enrollment | 20,000 |
| Start date | Jul 1, 2003 |
| Completion | Feb 1, 2011 |
| First posted | Feb 6, 2006 |
| Last update posted | May 16, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: